The global market for Infectious Disease Therapeutics was valued at US$ 49180 million in the year 2024 and is projected to reach a revised size of US$ 63380 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Infectious Disease Therapeutics Market

Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Infectious Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Therapeutics.

The Infectious Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Infectious Disease Therapeutics Market Report

Report Metric	Details
Report Name	Infectious Disease Therapeutics Market
Accounted market size in year	US$ 49180 million
Forecasted market size in 2031	US$ 63380 million
CAGR	3.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Drugs Vaccines
Segment by Application	HIV/AIDS Influenza Hepatitis Malaria Tuberculosis Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals Inc., Merck & Co. Inc., Boehringer Ingelheim GmbH
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Infectious Disease Therapeutics Market growing?

Ans: The Infectious Disease Therapeutics Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Infectious Disease Therapeutics Market size in 2031?

Ans: The Infectious Disease Therapeutics Market size in 2031 will be US$ 63380 million.

Who are the main players in the Infectious Disease Therapeutics Market report?

Ans: The main players in the Infectious Disease Therapeutics Market are Novartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals Inc., Merck & Co. Inc., Boehringer Ingelheim GmbH

What are the Application segmentation covered in the Infectious Disease Therapeutics Market report?

Ans: The Applications covered in the Infectious Disease Therapeutics Market report are HIV/AIDS, Influenza, Hepatitis, Malaria, Tuberculosis, Others

What are the Type segmentation covered in the Infectious Disease Therapeutics Market report?

Ans: The Types covered in the Infectious Disease Therapeutics Market report are Drugs, Vaccines

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Drugs

1.2.3 Vaccines

1.3 Market by Application

1.3.1 Global Infectious Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 HIV/AIDS

1.3.3 Influenza

1.3.4 Hepatitis

1.3.5 Malaria

1.3.6 Tuberculosis

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infectious Disease Therapeutics Market Perspective (2020-2031)

2.2 Global Infectious Disease Therapeutics Growth Trends by Region

2.2.1 Global Infectious Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Infectious Disease Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Infectious Disease Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Infectious Disease Therapeutics Market Dynamics

2.3.1 Infectious Disease Therapeutics Industry Trends

2.3.2 Infectious Disease Therapeutics Market Drivers

2.3.3 Infectious Disease Therapeutics Market Challenges

2.3.4 Infectious Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Infectious Disease Therapeutics Players by Revenue

3.1.1 Global Top Infectious Disease Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Infectious Disease Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Infectious Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Infectious Disease Therapeutics Revenue

3.4 Global Infectious Disease Therapeutics Market Concentration Ratio

3.4.1 Global Infectious Disease Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Therapeutics Revenue in 2024

3.5 Global Key Players of Infectious Disease Therapeutics Head office and Area Served

3.6 Global Key Players of Infectious Disease Therapeutics, Product and Application

3.7 Global Key Players of Infectious Disease Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Therapeutics Breakdown Data by Type

4.1 Global Infectious Disease Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Infectious Disease Therapeutics Forecasted Market Size by Type (2026-2031)

5 Infectious Disease Therapeutics Breakdown Data by Application

5.1 Global Infectious Disease Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Infectious Disease Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Infectious Disease Therapeutics Market Size (2020-2031)

6.2 North America Infectious Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Infectious Disease Therapeutics Market Size by Country (2020-2025)

6.4 North America Infectious Disease Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Infectious Disease Therapeutics Market Size (2020-2031)

7.2 Europe Infectious Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Infectious Disease Therapeutics Market Size by Country (2020-2025)

7.4 Europe Infectious Disease Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Infectious Disease Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Infectious Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Infectious Disease Therapeutics Market Size (2020-2031)

9.2 Latin America Infectious Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Infectious Disease Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Infectious Disease Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Infectious Disease Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Infectious Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis AG

11.1.1 Novartis AG Company Details

11.1.2 Novartis AG Business Overview

11.1.3 Novartis AG Infectious Disease Therapeutics Introduction

11.1.4 Novartis AG Revenue in Infectious Disease Therapeutics Business (2020-2025)

11.1.5 Novartis AG Recent Development

11.2 Gilead

11.2.1 Gilead Company Details

11.2.2 Gilead Business Overview

11.2.3 Gilead Infectious Disease Therapeutics Introduction

11.2.4 Gilead Revenue in Infectious Disease Therapeutics Business (2020-2025)

11.2.5 Gilead Recent Development

11.3 GlaxoSmithKline plc

11.3.1 GlaxoSmithKline plc Company Details

11.3.2 GlaxoSmithKline plc Business Overview

11.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Introduction

11.3.4 GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2020-2025)

11.3.5 GlaxoSmithKline plc Recent Development

11.4 Janssen Pharmaceutical Inc.

11.4.1 Janssen Pharmaceutical Inc. Company Details

11.4.2 Janssen Pharmaceutical Inc. Business Overview

11.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Introduction

11.4.4 Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2020-2025)

11.4.5 Janssen Pharmaceutical Inc. Recent Development

11.5 F. Hoffmann-La Roche Ltd.

11.5.1 F. Hoffmann-La Roche Ltd. Company Details

11.5.2 F. Hoffmann-La Roche Ltd. Business Overview

11.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Introduction

11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2020-2025)

11.5.5 F. Hoffmann-La Roche Ltd. Recent Development

11.6 BioCryst Pharmaceuticals Inc.

11.6.1 BioCryst Pharmaceuticals Inc. Company Details

11.6.2 BioCryst Pharmaceuticals Inc. Business Overview

11.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Introduction

11.6.4 BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2020-2025)

11.6.5 BioCryst Pharmaceuticals Inc. Recent Development

11.7 Merck & Co. Inc.

11.7.1 Merck & Co. Inc. Company Details

11.7.2 Merck & Co. Inc. Business Overview

11.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Introduction

11.7.4 Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2020-2025)

11.7.5 Merck & Co. Inc. Recent Development

11.8 Boehringer Ingelheim GmbH

11.8.1 Boehringer Ingelheim GmbH Company Details

11.8.2 Boehringer Ingelheim GmbH Business Overview

11.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Introduction

11.8.4 Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2020-2025)

11.8.5 Boehringer Ingelheim GmbH Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Gilead

GlaxoSmithKline PLC

Janssen Pharmaceutical Inc.

F Hoffmann La Roche Ltd

BioCryst Pharmaceuticals Inc

Merck& Co. Inc

Boehringer Ingelheim GmbH

List of Tables

Table 1. Global Infectious Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Drugs

Table 3. Key Players of Vaccines

Table 4. Global Infectious Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Infectious Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Infectious Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Infectious Disease Therapeutics Market Share by Region (2020-2025)

Table 8. Global Infectious Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Infectious Disease Therapeutics Market Share by Region (2026-2031)

Table 10. Infectious Disease Therapeutics Market Trends

Table 11. Infectious Disease Therapeutics Market Drivers

Table 12. Infectious Disease Therapeutics Market Challenges

Table 13. Infectious Disease Therapeutics Market Restraints

Table 14. Global Infectious Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Infectious Disease Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Therapeutics as of 2024)

Table 17. Ranking of Global Top Infectious Disease Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Infectious Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Infectious Disease Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Infectious Disease Therapeutics, Product and Application

Table 21. Global Key Players of Infectious Disease Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Infectious Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Infectious Disease Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Infectious Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Infectious Disease Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Infectious Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Infectious Disease Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Infectious Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Infectious Disease Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Infectious Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Infectious Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Infectious Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Infectious Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Infectious Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Infectious Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Infectious Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Infectious Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Infectious Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Infectious Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Infectious Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Novartis AG Company Details

Table 47. Novartis AG Business Overview

Table 48. Novartis AG Infectious Disease Therapeutics Product

Table 49. Novartis AG Revenue in Infectious Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Novartis AG Recent Development

Table 51. Gilead Company Details

Table 52. Gilead Business Overview

Table 53. Gilead Infectious Disease Therapeutics Product

Table 54. Gilead Revenue in Infectious Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Gilead Recent Development

Table 56. GlaxoSmithKline plc Company Details

Table 57. GlaxoSmithKline plc Business Overview

Table 58. GlaxoSmithKline plc Infectious Disease Therapeutics Product

Table 59. GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 60. GlaxoSmithKline plc Recent Development

Table 61. Janssen Pharmaceutical Inc. Company Details

Table 62. Janssen Pharmaceutical Inc. Business Overview

Table 63. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product

Table 64. Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Janssen Pharmaceutical Inc. Recent Development

Table 66. F. Hoffmann-La Roche Ltd. Company Details

Table 67. F. Hoffmann-La Roche Ltd. Business Overview

Table 68. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product

Table 69. F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 70. F. Hoffmann-La Roche Ltd. Recent Development

Table 71. BioCryst Pharmaceuticals Inc. Company Details

Table 72. BioCryst Pharmaceuticals Inc. Business Overview

Table 73. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product

Table 74. BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 75. BioCryst Pharmaceuticals Inc. Recent Development

Table 76. Merck & Co. Inc. Company Details

Table 77. Merck & Co. Inc. Business Overview

Table 78. Merck & Co. Inc. Infectious Disease Therapeutics Product

Table 79. Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Merck & Co. Inc. Recent Development

Table 81. Boehringer Ingelheim GmbH Company Details

Table 82. Boehringer Ingelheim GmbH Business Overview

Table 83. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product

Table 84. Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Boehringer Ingelheim GmbH Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Infectious Disease Therapeutics Picture

Figure 2. Global Infectious Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Infectious Disease Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Drugs Features

Figure 5. Vaccines Features

Figure 6. Global Infectious Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Infectious Disease Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. HIV/AIDS Case Studies

Figure 9. Influenza Case Studies

Figure 10. Hepatitis Case Studies

Figure 11. Malaria Case Studies

Figure 12. Tuberculosis Case Studies

Figure 13. Others Case Studies

Figure 14. Infectious Disease Therapeutics Report Years Considered

Figure 15. Global Infectious Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Infectious Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Infectious Disease Therapeutics Market Share by Region: 2024 VS 2031

Figure 18. Global Infectious Disease Therapeutics Market Share by Players in 2024

Figure 19. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Therapeutics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Therapeutics Revenue in 2024

Figure 21. North America Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Infectious Disease Therapeutics Market Share by Country (2020-2031)

Figure 23. United States Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Infectious Disease Therapeutics Market Share by Country (2020-2031)

Figure 27. Germany Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Infectious Disease Therapeutics Market Share by Region (2020-2031)

Figure 35. China Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Infectious Disease Therapeutics Market Share by Country (2020-2031)

Figure 43. Mexico Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Infectious Disease Therapeutics Market Share by Country (2020-2031)

Figure 47. Turkey Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Infectious Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Novartis AG Revenue Growth Rate in Infectious Disease Therapeutics Business (2020-2025)

Figure 51. Gilead Revenue Growth Rate in Infectious Disease Therapeutics Business (2020-2025)

Figure 52. GlaxoSmithKline plc Revenue Growth Rate in Infectious Disease Therapeutics Business (2020-2025)

Figure 53. Janssen Pharmaceutical Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2020-2025)

Figure 54. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Infectious Disease Therapeutics Business (2020-2025)

Figure 55. BioCryst Pharmaceuticals Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2020-2025)

Figure 56. Merck & Co. Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2020-2025)

Figure 57. Boehringer Ingelheim GmbH Revenue Growth Rate in Infectious Disease Therapeutics Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4U20267

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-16R16865

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-3F17301

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-4B20221

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Infectious Disease Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-1D13526

Global Infectious Disease Therapeutics Market Research Report 2025

FEATURED COMPANIES

Infectious Disease Therapeutics Market Size

Infectious Disease Therapeutics Market

Scope of Infectious Disease Therapeutics Market Report

Chapter Outline

FAQ for this report

How fast is Infectious Disease Therapeutics Market growing?

What is the Infectious Disease Therapeutics Market size in 2031?

Who are the main players in the Infectious Disease Therapeutics Market report?

What are the Application segmentation covered in the Infectious Disease Therapeutics Market report?

What are the Type segmentation covered in the Infectious Disease Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS